玮俊生物科技宣布推迟发送一份关联交易通告,该通告涉及特定授权下提议的新可转换债券发行事宜。原定于2025年7月7日前送达股东的文件,现因需额外时间完善某些信息,预计将延后至2025年7月31日发出。此公告由公司主席兼首席执行官林嘉骏于2025年7月15日正式公布。
玮俊生物科技宣布推迟发送一份关联交易通告,该通告涉及特定授权下提议的新可转换债券发行事宜。原定于2025年7月7日前送达股东的文件,现因需额外时间完善某些信息,预计将延后至2025年7月31日发出。此公告由公司主席兼首席执行官林嘉骏于2025年7月15日正式公布。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.